Welcome to The Mix Crawford Downs: Ok, so we've developed a novel episcopic fluorescent image capture device, it's automated, and basically what this does is allow us to capture…By: University of Alabama at Birmingham
This here's the Hydrus™ Microstent. What this does is it's a stent the goes through here the Trabecular Meshwork and stents open the Schlemm's canal for a number of clock…By: San Marino Eye | David D. Richardson, MD, Inc.
So what’s in the pipeline? Next-generation medications and surgeries in the pipe line. Medications Quickly, the medications that are—that you’re going to see—some of these are already…By: San Marino Eye | David D. Richardson, MD, Inc.
So in terms of the Beta-blockers—Timoptic, Betaxolol (and others) pretty much, all we use is Timoptic for most of our patients unless they’ve got some cardiovascular issues. These have…By: San Marino Eye | David D. Richardson, MD, Inc.
We're changing the future of visual field technology. The era of requiring patients to keep still and subjectively reacting to what they see by pressing a button is over. By using…By: Tosh Lubek
What do I consider the most promising? Interestingly enough, this is something that was just presented at a conference a month ago and I do you think this is the most promising of the…By: San Marino Eye | David D. Richardson, MD, Inc.
Continuous Wave Cyclophotocoagulation This is, traditionally been, reserved for those patients who have end-stage glaucoma where there’s no potential for vision. It’s just a blind,…By: San Marino Eye | David D. Richardson, MD, Inc.
So why don't we start with - (again well, I got these up here just to help us mentally categorize these things) so in terms of the non-invasive, enhancing procedures, laser Trabeculoplasty.…By: San Marino Eye | David D. Richardson, MD, Inc.